Description:Rabbit polyclonal antibody to ACVR1BImmunogen:KLH-conjugated synthetic peptide encompassing a sequence within the center region of human ACVR1B. The exact sequence is proprietary.Purification:The antibody was purified by immunogen affinity chromatography.Clonality:PolyclonalForm:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution:WB (1/500 - 1/1000), IH (1/50 - 1/100), IF/IC (1/50 - 1/200)Gene Symbol:ACVR1BAlternative Names:ACVRLK4; ALK4; Activin receptor type-1B; Activin receptor type IB; ACTR-IB; Activin receptor-like kinase 4; ALK-4; Serine/threonine-protein kinase receptor R2; SKR2
Entrez Gene (Human):
91;
Entrez Gene (Mouse):
11479;
Entrez Gene (Rat):
29381;
SwissProt (Human):
P36896;
SwissProt (Mouse):
Q61271;
SwissProt (Rat):
P80202;
Storage/Stability:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of ACVR1B expression in Hela (A), mouse liver (B), rat lung (C), rat spleen (D) whole cell lysates. (Predicted band size: 56 kD; Observed band size: 65 kD)
-
Immunohistochemical analysis of ACVR1B staining in human lymph node formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
-
Immunofluorescent analysis of ACVR1B staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a hidified chamber. Cells were washed with PBST and incubated with a AF594-conjugated secondary antibody (red) in PBS at room temperature in the dark.
Critical roles of miRNA-mediated regulation of TGFß signalling during mouse cardiogenesis